Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Hasidic doctor spouts conspiracy theories, anti-vaccine sentiment in video

The Hasidic doctor behind an unsubstantiated treatment for coronavirus espoused anti-vaccine and conspiracist views in a video circulating on WhatsApp among Haredi, or Ultra-Orthodox Jews.

Dr. Vladimir Zelenko, the man behind a treatment regimen involving the antimalarial drug hydroxychloroquine adopted by President Donald Trump, said in an undated interview with an Israeli rabbinical leader that people like George Soros and Bill Gates are involved in a “war against God” designed to “maintain global fear” as a part of an effort to “reorganize the social structure and fabric of the world.”

“There are properties in this vaccine which may inhibit fertility for young girls,” Zelenko said, without evidence, to Rabbi Amnon Yitzhak. “Also, there’s small particles called nanoparticles in this vaccine that may have the ability to track someone. In other words, with the increasing satellite networks, it may be very possible to have a GPS inside of every person.”

There is no evidence to suggest that vaccine manufacturers will attempt to track patients’ locations, and the coronavirus vaccine does not cause infertility.

Zelenko has indicated he has personal conversations with Trump, and attended the rally in Washington, D.C. last week that turned into an insurrection at the Capitol.

Zelenko said during the interview that the conspiracy “may go back to even Carnegie; it may go back to Vanderbilt.”

Yitzhak, the rabbi who interviewed Zelenko, has made a number of unsubstantiated claims and predictions over the course of his career, including one about an impending global conflict in 2014 that was supposed to wipe out non-Jews.

Zelenko’s conspiracy theory about vaccines is just one spreading among a population especially prone to disinformation after last week’s Capitol siege. In a Haredi WhatsApp channel on Monday, users traded tips about switching messaging applications and wrapping phones in aluminum foil to avoid shutdowns and surveillance, and selling stocks in preparation for civil unrest.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning journalism this Passover.

In this age of misinformation, our work is needed like never before. We report on the news that matters most to American Jews, driven by truth, not ideology.

At a time when newsrooms are closing or cutting back, the Forward has removed its paywall. That means for the first time in our 126-year history, Forward journalism is free to everyone, everywhere. With an ongoing war, rising antisemitism, and a flood of disinformation that may affect the upcoming election, we believe that free and open access to Jewish journalism is imperative.

Readers like you make it all possible. Right now, we’re in the middle of our Passover Pledge Drive and we still need 300 people to step up and make a gift to sustain our trustworthy, independent journalism.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Only 300 more gifts needed by April 30

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.